Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “18F-PSMA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03903419
What this trial is testing

Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients

Who this might be right for
Glioblastomas
Centre Leon Berard 16
Not applicableLooking for participantsNCT06917781
What this trial is testing

Prostate Cancer Burden and Heterogeneity Evaluation Towards Liquid Biopsy: a Correlation Study to 18FDCFPyL PET and Patients Outcome

Who this might be right for
Prostate Cancer
Institut Claudius Regaud 80
Testing effectiveness (Phase 2)Looking for participantsNCT05761366
What this trial is testing

Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor

Who this might be right for
Malignancy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 400
Large-scale testing (Phase 3)Study completedNCT02981368
What this trial is testing

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Progenics Pharmaceuticals, Inc. 385
Not applicableUnknownNCT05448404
What this trial is testing

A Head-to-head Comparative Study of 18F-PSMA-1007 PET/CT and 18F-FDG PET/CT Imaging in Multiple Myeloma

Who this might be right for
Multiple Myeloma
First Hospital of China Medical University 30
Not applicableLooking for participantsNCT07258056
What this trial is testing

GUidance In Prostate Cancer DEtection With 18F-PSMA-1007-PET/MRI and Targeted Biopsies

Who this might be right for
Prostate Cancer
Mads Ryo Jochumsen 100
Not applicableUnknownNCT04588454
What this trial is testing

18F-PSMA PET/CT for Visualization of Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Radboud University Medical Center 5
Testing effectiveness (Phase 2)Looking for participantsNCT04573231
What this trial is testing

Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Who this might be right for
Breast CancerHER2-negative Breast CancerMetastatic Breast Cancer
University of Wisconsin, Madison 13
Not applicableUnknownNCT03609736
What this trial is testing

PSMA-based 18F-DCFPyL PET/CT: Evaluating Its Application in Real Life

Who this might be right for
Prostate Cancer
Grand River Hospital 12
Not applicableStudy completedNCT05534594
What this trial is testing

Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid CancerMedullary Thyroid CarcinomaThyroid Carcinoma, Medullary+1 more
University Medical Center Groningen 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT03173924
What this trial is testing

18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate CancerProstatic NeoplasmsProstate Cancer+2 more
National Cancer Institute (NCI) 96
Testing effectiveness (Phase 2)Study completedNCT03939689
What this trial is testing

I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).

Who this might be right for
Metastatic Prostate CancerCastration-resistant Prostate CancerProstatic Neoplasm+2 more
Progenics Pharmaceuticals, Inc. 120
Post-approval studies (Phase 4)Looking for participantsNCT07569926
What this trial is testing

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 142
Large-scale testing (Phase 3)Study completedNCT04838626
What this trial is testing

Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection

Who this might be right for
Prostatic NeoplasmsProstate Cancer
Novartis Pharmaceuticals 195
Post-approval studies (Phase 4)Looking for participantsNCT06706921
What this trial is testing

18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstatic Neoplasms, Castration-ResistantMetastatic Prostate Cancer+8 more
VA Greater Los Angeles Healthcare System 15
Not applicableUnknownNCT06433063
What this trial is testing

Effect of Hypoxia on FMISO PET to Response to Lu-177 PSMA Treatment

Who this might be right for
Prostatic NeoplasmsHypoxia
Cigdem Soydal 30
Not applicableStudy completedNCT05958004
What this trial is testing

The Application Value of Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA Grey Area Prostate Cancer

Who this might be right for
Prostatic Neoplasms
First Affiliated Hospital Xi'an Jiaotong University 92
Not applicableEnded earlyNCT05123300
What this trial is testing

PRISMA-PET - Primary Staging of Prostate Cancer With PSMA

Who this might be right for
Prostate Cancer
Odense University Hospital 385
Large-scale testing (Phase 3)Study completedNCT04186819
What this trial is testing

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 356
Very early researchStudy completedNCT02190279
What this trial is testing

18F-DCFBC PET/CT in Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstate Cancer
National Cancer Institute (NCI) 116
Next Page